Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Markowitz

Showing results (481-490 of 583) with videos related to

Pageof 59
Sort By:
Journal of Acquired Immune Deficiency Syndromes (1999)|May 8, 2025
Vaccine effectiveness against anal HPV infection among men with HIV who have sex with men attending sexual health clinics in three United States cities, 2018-2023Carla L DeSisto, Damilola Dada, Preeti Pathela, et al.
Journal of the American Board of Family Medicine : JABFM|January 16, 2021
US Primary Care Physicians' Viewpoints on HPV Vaccination for Adults 27 to 45 YearsLaura P Hurley, Sean T O'Leary, Lauri E Markowitz, et al.
The Journal of Infectious Diseases|August 9, 2024
Vaccine Effectiveness Against Anal HPV Among Men Who Have Sex With Men Aged 18-45 Years Attending Sexual Health Clinics in 3 United States Cities, 2018-2023Carla L DeSisto, Rachel L Winer, Troy D Querec, et al.
JAMA|August 20, 2009
Postlicensure safety surveillance for quadrivalent human papillomavirus recombinant vaccineBarbara A Slade, Laura Leidel, Claudia Vellozzi, et al.
Inflammatory Bowel Diseases|October 9, 2004
Intestinal interleukin-13 in pediatric inflammatory bowel disease patientsKhadijeh Kadivar, Eduardo D Ruchelli, Jonathan E Markowitz, et al.
American Journal of Epidemiology|November 5, 2019
Effectiveness of 1, 2, and 3 Doses of Human Papillomavirus Vaccine Against High-Grade Cervical Lesions Positive for Human Papillomavirus 16 or 18Michelle L Johnson Jones, Julia Warner Gargano, Melissa Powell, et al.
MMWR. Morbidity and Mortality Weekly Report|August 22, 2024
National Vaccination Coverage Among Adolescents Aged 13-17 Years - National Immunization Survey-Teen, United States, 2023Cassandra Pingali, David Yankey, Michael Chen, et al.
Cancer|May 11, 2013
Individual and geographic disparities in human papillomavirus types 16/18 in high-grade cervical lesions: Associations with race, ethnicity, and povertyLinda M Niccolai, Chelsea Russ, Pamela J Julian, et al.
Journal of Lower Genital Tract Disease|March 22, 2022
Changes in Cervical Cytology Results and Human Papillomavirus Types Among Persons Screened for Cervical Cancer, 2007 and 2015-2017Rayleen M Lewis, Allison L Naleway, Nicola P Klein, et al.
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|December 1, 1996
Correlation of genetic and serologic approaches to HIV-1 subtyping in ThailandJ Gaywee, A W Artenstein, T C VanCott, et al.
Pageof 59

Showing results (481-490 of 583) with videos related to

Sort By:
Pageof 59
Journal of Acquired Immune Deficiency Syndromes (1999)|May 8, 2025
Vaccine effectiveness against anal HPV infection among men with HIV who have sex with men attending sexual health clinics in three United States cities, 2018-2023Carla L DeSisto, Damilola Dada, Preeti Pathela, et al.
Journal of the American Board of Family Medicine : JABFM|January 16, 2021
US Primary Care Physicians' Viewpoints on HPV Vaccination for Adults 27 to 45 YearsLaura P Hurley, Sean T O'Leary, Lauri E Markowitz, et al.
The Journal of Infectious Diseases|August 9, 2024
Vaccine Effectiveness Against Anal HPV Among Men Who Have Sex With Men Aged 18-45 Years Attending Sexual Health Clinics in 3 United States Cities, 2018-2023Carla L DeSisto, Rachel L Winer, Troy D Querec, et al.
JAMA|August 20, 2009
Postlicensure safety surveillance for quadrivalent human papillomavirus recombinant vaccineBarbara A Slade, Laura Leidel, Claudia Vellozzi, et al.
Inflammatory Bowel Diseases|October 9, 2004
Intestinal interleukin-13 in pediatric inflammatory bowel disease patientsKhadijeh Kadivar, Eduardo D Ruchelli, Jonathan E Markowitz, et al.
American Journal of Epidemiology|November 5, 2019
Effectiveness of 1, 2, and 3 Doses of Human Papillomavirus Vaccine Against High-Grade Cervical Lesions Positive for Human Papillomavirus 16 or 18Michelle L Johnson Jones, Julia Warner Gargano, Melissa Powell, et al.
MMWR. Morbidity and Mortality Weekly Report|August 22, 2024
National Vaccination Coverage Among Adolescents Aged 13-17 Years - National Immunization Survey-Teen, United States, 2023Cassandra Pingali, David Yankey, Michael Chen, et al.
Cancer|May 11, 2013
Individual and geographic disparities in human papillomavirus types 16/18 in high-grade cervical lesions: Associations with race, ethnicity, and povertyLinda M Niccolai, Chelsea Russ, Pamela J Julian, et al.
Journal of Lower Genital Tract Disease|March 22, 2022
Changes in Cervical Cytology Results and Human Papillomavirus Types Among Persons Screened for Cervical Cancer, 2007 and 2015-2017Rayleen M Lewis, Allison L Naleway, Nicola P Klein, et al.
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|December 1, 1996
Correlation of genetic and serologic approaches to HIV-1 subtyping in ThailandJ Gaywee, A W Artenstein, T C VanCott, et al.
Pageof 59